Search

everythinglearnresearchcommunity

for

Search:↓

About 7% to 15% of Iranian women have polycystic ovary syndrome, depending on the criteria used to diagnose it.

Polycystic Ovary Syndrome likely starts in childhood and may be genetic and influenced by early hormone exposure.

PCOS starts in adolescence with hormonal issues, leading to adult health problems, and early treatment is crucial.

Finasteride reduces hair growth better, but spironolactone has more side effects.

Finasteride is a safe, effective treatment for hirsutism with fewer side effects.

The conclusion is that the best initial treatment for hirsutism is usually oral contraceptives, with the addition of antiandrogens or insulin sensitizers if needed, and topical eflornithine or laser treatments as supplementary options.

Oral contraceptives help treat hyperandrogenic disorders, improving symptoms like excessive hair and acne.

All three treatments reduce hirsutism, but spironolactone works best long-term.

Minoxidil helps hair regrowth in alopecia areata safely.

High androgen levels in Chinese women with PCOS are linked to a higher risk of diabetes and obesity.

About 13% of women had idiopathic hirsutism and 8.5% had polycystic ovary syndrome in a group of Iranian women.

Low-dose finasteride effectively treats hirsutism, is safe, and cost-effective.

Finasteride effectively treats hirsutism in women, but more research needed for long-term results.

Some women with PCOS have CYP21 mutations and IRS1 variants, but these genetic factors are not major contributors to PCOS.

About 3% of high school girls aged 14-18 in Isfahan, Iran, have polycystic ovary syndrome.

Women with PCOS are more likely to have fatty liver disease and worse metabolic health.

Doctors should know how to diagnose and treat PCOS, which often involves checking for high male hormone levels and using medications to manage symptoms.

Finasteride reduces hair growth and is safe for women with excessive hair.

Women with severe types of PCOS are more likely to have metabolic syndrome, and belly fat is a key predictor of this risk.

The research found different metabolism changes in PCOS patients and suggested new potential markers for diagnosing PCOS with or without insulin resistance.

People with hair loss may have different levels of certain hormones due to changes in hormone processing.

More adolescent girls in urban areas of India have Polycystic Ovary Syndrome compared to those in rural areas.

The N363S gene variant does not cause higher adrenal androgen levels in women with polycystic ovary syndrome.

The document concludes that careful evaluation is needed to diagnose PCOS correctly due to similar symptoms in other conditions, and accurate testosterone level measurement is crucial.

Women with PCOS in Sicily show different levels of metabolic problems depending on their PCOS type, with obesity and abnormal lipid profiles being common.

Treating excessive hair in women requires a holistic approach, including medical, aesthetic, and emotional support.

Women with Polycystic Ovary Syndrome (PCOS) have a lower health-related quality of life, especially those with an anovulatory phenotype, and may need specific interventions to improve it.

The conclusion is that while oral contraceptive pills are effective for PCOS-related high androgen levels, new treatments with fewer side effects are needed.

The conclusion is that a thorough approach is needed to diagnose and manage hyperandrogenism in teenage girls, recognizing its major psychological and health effects.

Women with nonclassic congenital adrenal hyperplasia experience more sexual dysfunction and distress.